GlassScriptPhysician profile
Gregory Wynn
NPI 1376550855
$1,137.67
in general payments reported to CMS, 2019-2025
20 companies · $164 in 2025
The $164 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $306 · 2020: $50.58 · 2021: $115 · 2022: $32.82 · 2023: $241 · 2024: $229 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $633.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $266.30 | 2022-2025 | Azstarys |
| Cranial Technologies, INC | $110.80 | 2019-2023 | Doc Band |
| Sobi, INC | $105.64 | 2019-2023 | |
| Sanofi Pasteur INC. | $103.67 | 2019-2024 | |
| Glaxosmithkline, LLC. | $96.28 | 2019-2021 | |
| Tris Pharma INC | $88.07 | 2019-2025 | Onyda Xr |
| Ironshore Pharmaceuticals INC. | $70.26 | 2019-2024 | |
| Pfizer INC. | $51.43 | 2019-2023 | |
| Collegium Pharmaceutical, INC. | $35.99 | 2025 | Jornay Pm |
| Ars Pharmaceuticals Operations, INC. | $27.09 | 2025 | Neffy |
| Merck Sharp & Dohme LLC | $26.78 | 2019 | |
| Neurelis, INC. | $26.14 | 2023 | Valtoco |
| Meridian Bioscience INC. | $22.09 | 2019 | |
| Sanofi-Aventis U.S. LLC | $19.14 | 2025 | |
| Kaleo, INC. | $17.58 | 2023 | Auvi-Q |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $16.55 | 2023 | Immunocap |
| Verrica Pharmaceuticals INC. | $13.98 | 2024 | Ycanth |
| Pharming Healthcare, INC. | $13.82 | 2023 | Ruconest |
| Supernus Pharmaceuticals, INC. | $13.07 | 2024 | Qelbree |
| Arbor Pharmaceuticals, INC. | $12.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Wynn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.